bpc-157 news today fda 🚨 HUGE FOR 🚨 Today, the FDA's Pharmacy Compounding Advisory Committee voted 8–6, with 1 abstention, in favor of recommending BPC-157 for inclusion on the 503A Bulk Drug Substances List FDA panel votes to ease

Critical Calculations: Getting Your Dilution Ratios Right Lets be honest, the math can be intimidating for some

Given the FDAs April 2025 alert, informed consent for compounded topical finasteride should cover systemic absorption risk, known side effects (sexual, neuropsychiatric), transfer risk to household members (especially women of childbearing age), and the non-FDA-approved status of the formulation

Drug Interactions That Could Amplify Overdose Risk BPC-157 does not appear in any formal drug interaction database because it lacks regulatory approval

Factors that might contribute to weight changes Several factors may contribute to weight changes while using a particular type of contraception

For single-dose, single-use only